Cite
Mesenchymal stromal cell treatment attenuates repetitive mild traumatic brain injury-induced persistent cognitive deficits via suppressing ferroptosis
MLA
Dong Wang, et al. “Mesenchymal Stromal Cell Treatment Attenuates Repetitive Mild Traumatic Brain Injury-Induced Persistent Cognitive Deficits via Suppressing Ferroptosis.” Journal of Neuroinflammation, vol. 19, no. 1, July 2022, pp. 1–19. EBSCOhost, https://doi.org/10.1186/s12974-022-02550-7.
APA
Dong Wang, Shishuang Zhang, Xintong Ge, Zhenyu Yin, Meimei Li, Mengtian Guo, Tianpeng Hu, Zhaoli Han, Xiaodong Kong, Dai Li, Jing Zhao, Lu Wang, Qiang Liu, Fanglian Chen, & Ping Lei. (2022). Mesenchymal stromal cell treatment attenuates repetitive mild traumatic brain injury-induced persistent cognitive deficits via suppressing ferroptosis. Journal of Neuroinflammation, 19(1), 1–19. https://doi.org/10.1186/s12974-022-02550-7
Chicago
Dong Wang, Shishuang Zhang, Xintong Ge, Zhenyu Yin, Meimei Li, Mengtian Guo, Tianpeng Hu, et al. 2022. “Mesenchymal Stromal Cell Treatment Attenuates Repetitive Mild Traumatic Brain Injury-Induced Persistent Cognitive Deficits via Suppressing Ferroptosis.” Journal of Neuroinflammation 19 (1): 1–19. doi:10.1186/s12974-022-02550-7.